| Product Name | ent-Aprepitant-13C15N2 |
| Product Code | DA-A280-21 |
| Chemical name | ent-Aprepitant-13C15N2 |
| Synonyms | 5-(((2S,3R)-2-((S)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one-3-13C-1,2-15N2; 5-[[(2S,3R)-2-[(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one-13C15N2; [2S-[2α(R*),3α]]-5-[[2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one-13C15N2; |
| Impurity | NA |
| CAS Number | 2724540-72-9 |
| Alternate CAS # | NA |
| Molecular form | C2213CH21F7N215N2O3 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 537.40 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | chiral standards,heterocycles,pharmaceutical standards,intermediates,Fine Chemicals,stable isotopes |
| Boiling Point | NA |
| Applications | Isotope Labelled (S,R,S)-enantiomer of Aprepitant, an unwanted enantiomer of Aprepitant in bulk drug and formulation samples of Aprepitant. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
| NA |
